Royal Bank of Canada
ARNA

Royal Bank of Canada’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Royal Bank of Canada’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,000
Closed -$53K – 6230
2013
Q3 		$53K Buy
+1,000
New +$67.1K ﹤0.01% 4789

Royal Bank of Canada's ARNA Position: Q1 2022 in Review

Royal Bank of Canada sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 38,010 shares — an estimated $3.53M sold.

Royal Bank of Canada first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $3.53M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Royal Bank of Canada reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 38,010 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.53M.
  • Royal Bank of Canada first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
  • Royal Bank of Canada's Arena Pharmaceuticals Inc position peaked at $3.53M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Royal Bank of Canada's 13F filing for Q1 2022, filed 16 May 2022.